Euroapi SAS
PAR:EAPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alpha Financial Markets Consulting PLC
LSE:AFM
|
UK |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
LSE:0HAU
|
FR |
|
C
|
China Tianrui Group Cement Co Ltd
F:T18
|
CN |
|
Precigen Inc
NASDAQ:PGEN
|
US |
|
OCI NV
AEX:OCI
|
NL |
|
F
|
Fabasoft AG
XBER:FAA
|
AT |
|
Kongsberg Automotive ASA
OSE:KOA
|
NO |
|
I
|
Instal Krakow SA
WSE:INK
|
PL |
|
National Bank of Greece SA
OTC:NBGIF
|
GR |
Euroapi SAS
Stock-Based Compensation
Euroapi SAS
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Stock-Based Compensation
€2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Stock-Based Compensation
€319m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Ipsen SA
PAR:IPN
|
Stock-Based Compensation
€39.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Vetoquinol SA
PAR:VETO
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Virbac SA
PAR:VIRP
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medincell SA
PAR:MEDCL
|
Stock-Based Compensation
€3.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Stock-Based Compensation?
Stock-Based Compensation
2m
EUR
Based on the financial report for Dec 31, 2025, Euroapi SAS's Stock-Based Compensation amounts to 2m EUR.
What is Euroapi SAS's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
5%
Over the last year, the Stock-Based Compensation growth was -41%. The average annual Stock-Based Compensation growth rates for Euroapi SAS have been -46% over the past three years , 5% over the past five years .
